- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2021-003221-30. Displaying page 1 of 1.
|EudraCT Number: 2021-003221-30||Sponsor Protocol Number: D5290C00008||Start Date*: 2021-10-22|
|Sponsor Name:AstraZeneca AB|
|Full Title: A Phase 2, Open-label, Uncontrolled, Single-dose Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Occurrence of Antidrug Antibody for Nirsevimab in Immunocompromised Children ≤ ...|
|Medical condition: RSV disease|
|Population Age: Newborns, Infants and toddlers, Under 18||Gender: Male, Female|
|Trial protocol: ES (Ongoing) BE (Completed) PL (Completed)|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.